Characteristics of adults with Down syndrome: Prevalence of age-related conditions

Frontiers in Medicine

Volumn 1, Issue DEC, 2014, Pages

  Carfì, Angelo ^a   Antocicco, Manuela ^a   Brandi, Vincenzo ^a   Cipriani, Camilla ^a   Fiore, Francesca ^a   Mascia, Donatella ^a   Settanni, Silvana ^a   Vetrano, Davide L ^a   Bernabei, Roberto ^a   Onder, Graziano ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Aging; Down syndrome; Geriatric assessment; Geriatric syndromes; Multimorbidity; Premature

Indexed keywords

EID: 84943810368     PISSN: None     EISSN: 2296858X     Source Type: Journal    
DOI: 10.3389/fmed.2014.00051     Document Type: Article

References (32)

1. Oliver C, Holland AJ. Down's syndrome and Alzheimer's disease: a review. Psychol Med (1986) 16:307-22. doi: 10.1017/S0033291700009120
2. Yang Q, Rasmussen SA, Friedman JM. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet (2002) 359:1019-25. doi:10.1016/S0140-6736(02)08092-3
3. Centers for Disease Control and Prevention (CDC). Racial disparities in median age at death of persons with Down syndrome-United States, 1968-1997. MMWR Morb Mortal Wkly Rep (2001) 50:463-5
4. Glasson EJ, Sullivan SG, Hussain R, Petterson BA, Montgomery PD, Bittles AH. The changing survival profile of people with Down's syndrome: implications for genetic counselling. Clin Genet (2002) 62:390-3. doi:10.1034/j.1399-0004.2002.620506.x
5. Bittles AH, Glasson EJ. Clinical, social, and ethical implications of changing life expectancy in Down syndrome. Dev Med Child Neurol (2004) 46:282-6. doi:10.1111/j.1469-8749.2004.tb00483.x
6. Nakamura E, Tanaka S. Biological ages of adult men and women with Down's syndrome and its changes with aging. Mech Ageing Dev (1998) 105:89-103. doi:10.1016/S0047-6374(98)00081-5
7. Martin GM. Genetic syndromes in man with potential relevance to the pathobiology of aging. Birth Defects Orig Artic Ser (1978) 14:5-39
8. Martin GM. Genetic modulation of senescent phenotypes in Homo sapiens. Cell (2005) 120:523-32. doi:10.1016/j.cell.2005.01.031
9. Colvin L, Jurenka SB, Van Allen MI. Down syndrome. In: Hisami FM, Weissman SM, Martin G, editors. Chromosomal Instability and Aging. New York: Marcel Dekker (2003). p. 441-63
10. Thase ME. Longevity and mortality in Down's syndrome. J Ment Defic Res (1982) 26:177-92
11. Glasson EJ, Dye DE, Bittles AH. The triple challenges associated with age-related comorbidities in Down syndrome. J Intellect Disabil Res (2014) 58:393-8. doi:10.1111/jir.12026
12. Hartman DE. Wechsler Adult Intelligence Scale IV (WAIS IV): return of the gold standard. Appl Neuropsychol (2009) 16:85-7. doi:10.1080/09084280802644466
13. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA (1963) 185:914-9. doi:10.1001/jama.1963.03060120024016
14. Schoufour JD, Mitnitski A, Rockwood K, Hilgenkamp TI, Evenhuis HM, Echteld MA. Predicting disabilities in daily functioning in older people with intellectual disabilities using a frailty index. Res Dev Disabil (2014) 35:2267-77. doi:10.1016/j.ridd.2014.05.022
15. Lin LP, Hsu SW, Hsia YC, Wu CL, Chu C, Lin JD. Association of early-onset dementia with activities of daily living (ADL) in middle-aged adults with intellectual disabilities: the caregiver's perspective. Res Dev Disabil (2014) 35:626-31. doi:10.1016/j.ridd.2013.12.015
16. Lin LP, Hsia YC, Hsu SW, Loh CH, Wu CL, Lin JD. Caregivers' reported functional limitations in activities of daily living among middle-aged adults with intellectual disabilities. Res Dev Disabil (2013) 34:4559-64. doi:10.1016/j.ridd.2013.09.038
17. Wisniewski KE, Wisniewski HM, Wen GY. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol (1985) 17:278-82. doi:10.1002/ana.410170310
18. Wisniewski KE, French JH, Rosen JF, Kozlowski PB, Tenner M, Wisniewski HM. Basal ganglia calcification (BGC) in Down's syndrome (DS)-another manifestation of premature aging. Ann N Y Acad Sci (1982) 396:179-89. doi:10.1111/j.1749-6632.1982.tb26852.x
19. Mann DM, Esiri MM. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci (1989) 89:169-79. doi:10.1016/0022-510X(89)90019-1
20. Jensen KM, Davis MM. Health care in adults with Down syndrome: a longitudinal cohort study. J Intellect Disabil Res (2013) 57:947-58. doi:10.1111/j.1365-2788.2012.01589.x
21. Prasher VP, Huxley A, Haque MS. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease-pilot study. Int J Geriatr Psychiatry (2002) 17:270-8. doi:10.1002/gps.587
22. Hanney M, Prasher V, Williams N, Jones EL, Aarsland D, Corbett A, et al. Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial. Lancet (2012) 379:528-36. doi:10.1016/S0140-6736(11)61676-0
23. Mohan M, Carpenter PK, Bennett C. Donepezil for dementia in people with Down syndrome. Cochrane Database Syst Rev (2009):CD007178. doi:10.1002/14651858.CD007178.pub2
24. Mohan M, Bennett C, Carpenter PK. Rivastigmine for dementia in people with Down syndrome. Cochrane Database Syst Rev (2009):CD007658. doi:10.1002/14651858.CD007658
25. Mohan M, Bennett C, Carpenter PK. Galantamine for dementia in people with Down syndrome. Cochrane Database Syst Rev (2009):CD007656. doi:10.1002/14651858.CD007656
26. Mohan M, Bennett C, Carpenter PK. Memantine for dementia in people with Down syndrome. Cochrane Database Syst Rev (2009):CD007657. doi:10.1002/14651858.CD007657
27. McKelvey KD, Fowler TW, Akel NS, Kelsay JA, Gaddy D, Wenger GR, et al. Low bone turnover and low bone density in a cohort of adults with Down syndrome. Osteoporos Int (2013) 24:1333-8. doi:10.1007/s00198-012-2109-4
28. González-Agüero A, Vicente-Rodríguez G, Moreno LA, Casajús JA. Bone mass in male and female children and adolescents with Down syndrome. Osteoporos Int (2011) 22:2151-7. doi:10.1007/s00198-010-1443-7
29. Srikanth R, Cassidy G, Joiner C, Teeluckdharry S. Osteoporosis in people with intellectual disabilities: a review and a brief study of risk factors for osteoporosis in a community sample of people with intellectual disabilities. J Intellect Disabil Res (2011) 55:53-62. doi:10.1111/j.1365-2788.2010.01346.x
30. Baptista F, Varela A, Sardinha LB. Bone mineral mass in males and females with and without Down syndrome. Osteoporos Int (2005) 16:380-8. doi:10.1007/s00198-004-1687-1
31. Angelopoulou N, Souftas V, Sakadamis A, Mandroukas K. Bone mineral density in adults with Down's syndrome. Eur Radiol (1999) 9:648-51. doi:10.1007/s003300050726
32. Sepúlveda D, Allison DB, Gomez JE, Kreibich K, Brown RA, Pierson RN Jr, et al. Low spinal and pelvic bone mineral density among individuals with Down syndrome. Am J Ment Retard (1995) 100:109-14